Related Experiment Video
Updated: Jun 25, 2025
07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
2.7K
PKM2 promotes glioma progression by mediating CTNNB1 expression
Chunyang Ma1, Yuan Feng2, Kaiyi Zhong3
1Department of Neurosurgery, First Affiliated Hospital of Hainan Medical College, Haikou, Hainan, China.
Neurological Research
|May 26, 2024
Summary
Pyruvate kinase M2 (PKM2) promotes aggressive glioma growth by regulating CTNNB1 expression. Inhibiting PKM2 reduces tumor progression and increases apoptosis, offering a potential therapeutic target for glioma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Glioma is an aggressive brain tumor with high invasiveness.
- Pyruvate kinase M2 (PKM2) is frequently overexpressed in glioma tissues.
- The precise function of PKM2 in glioma pathogenesis remains largely undetermined.
Purpose of the Study:
- To elucidate the biological role and functional mechanisms of PKM2 in glioma progression.
- To investigate the interaction between PKM2 and other key proteins in glioma cells.
- To assess the therapeutic potential of targeting PKM2 in glioma.
Main Methods:
- Quantitative reverse transcription PCR (qRT-PCR) and Western blot assays to measure PKM2 expression.
- Cell proliferation (CCK-8), migration (Transwell), apoptosis (flow cytometry), and glycolysis assays.
- STRING database analysis and Co-immunoprecipitation (Co-IP) assays to identify and validate PKM2 interacting proteins.
- In vivo studies using transplanted tumor models in mice.
Main Results:
- PKM2 expression was significantly upregulated in glioma cells and tissues.
- PKM2 inhibition markedly decreased glioma cell proliferation, migration, glycolysis, and epithelial-mesenchymal transition (EMT), while increasing apoptosis.
- Bioinformatic analysis and Co-IP confirmed a strong interaction between PKM2 and catenin beta 1 (CTNNB1).
- Overexpression of CTNNB1 rescued the inhibitory effects of PKM2 knockdown on glioma cell behaviors.
- PKM2 knockdown suppressed tumor growth in vivo.
Conclusions:
- PKM2 plays a crucial role in promoting glioma progression by mediating CTNNB1 expression.
- PKM2 represents a potential molecular marker and therapeutic target for clinical management of gliomas.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.4K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
Related Concept Videos
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K